comparemela.com

Latest Breaking News On - Prnewswire eurofins viracor - Page 1 : comparemela.com

Eurofins Viracor Opens Expansive Laboratory in Lenexa, KS

110,000 square foot, state-of-the-art facility increases infectious disease and immunology testing capacity to support growth of clinical, biophar.

Eurofins Viracor Opens Expansive Laboratory in Lenexa, KS

/PRNewswire/ Eurofins Viracor, a leader in infectious disease and immunology testing, today celebrated the opening of its expansive new laboratory in.

Eurofins Viracor Opens Expansive Laboratory in Lenexa, KS

/PRNewswire/ Eurofins Viracor, a leader in infectious disease and immunology testing, today celebrated the opening of its expansive new laboratory in.

Eurofins Transplant Diagnostics Group Receives New York State CLEP Approval for Novel Rejection Biomarker Assays

Press release content from PR Newswire. The AP news staff was not involved in its creation. Eurofins Transplant Diagnostics Group Receives New York State CLEP Approval for Novel Rejection Biomarker Assays April 27, 2021 GMT Eurofins Transplant Diagnostics LEE’S SUMMIT, Mo. and FRAMINGHAM, Mass., April 27, 2021 /PRNewswire/ Eurofins Viracor, one of the largest and most recognized infectious diseases testing laboratories in the United States, and Transplant Genomics, the trusted global partner in precision biomarkers for the transplant community innovating to improve patient outcomes, announce that the New York State Department of Health Clinical Laboratory Evaluation Program (CLEP) has approved the Viracor TRAC™ (Transplant Allograft Rejection Check) donor-derived cell-free DNA test and TruGraf® blood gene expression test, both of which help healthcare providers assess rejection status in kidney transplant recipients.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.